These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10735781)

  • 1. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
    Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
    Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
    Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.
    Wang JS; Lin CY; Karp RB
    Anesth Analg; 1994 Jul; 79(1):9-13. PubMed ID: 8010461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose thrombin time versus the activated clotting time during cardiopulmonary bypass.
    de Jong MA
    J Extra Corpor Technol; 1999 Jun; 31(2):76-9. PubMed ID: 10724646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
    Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients.
    Dietrich W; Braun S; Spannagl M; Richter JA
    Anesth Analg; 2001 Jan; 92(1):66-71. PubMed ID: 11133602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin sensitivity test for patients requiring cardiopulmonary bypass.
    DeBois WJ; Liu J; Elmer B; Ebrahimi H; Voevidko L; Lee LY; Krieger KH; Isom WW; Girardi LN
    J Extra Corpor Technol; 2006 Dec; 38(4):307-9. PubMed ID: 17312901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
    Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat.
    Welsby IJ; Jones WL; Arepally G; De Lange F; Yoshitani K; Phillips-Bute B; Grocott HP; Becker R; Mackensen GB
    Anesthesiology; 2007 Feb; 106(2):295-301. PubMed ID: 17264724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.